Ionis Pharmaceuticals (IONS) Other Non-Current Assets (2009 - 2026)

Ionis Pharmaceuticals' Other Non-Current Assets history runs 18 years deep, the most recent figure standing at $135.6 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 2.83% year-over-year to $135.6 million; the TTM figure through Mar 2026 stood at $135.6 million (up 2.83% YoY), while the FY2025 annual figure was $171.6 million, up 34.83% from the prior year.
• Other Non-Current Assets was $135.6 million for Q1 2026 at Ionis Pharmaceuticals, down from $171.6 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $171.6 million in Q4 2025 to a low of $58.9 million in Q2 2022.
• Historically, Other Non-Current Assets has averaged $108.0 million across 5 years, with a median of $106.0 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Other Non-Current Assets soared 75.12% in 2023, then gained 2.83% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $75.3 million in 2022, then surged by 39.73% to $105.3 million in 2023, then advanced by 20.89% to $127.3 million in 2024, then soared by 34.83% to $171.6 million in 2025, then retreated by 21.0% to $135.6 million in 2026.
• The last three Other Non-Current Assets figures came in at $135.6 million (Q1 2026), $171.6 million (Q4 2025), and $166.0 million (Q3 2025), per Business Quant data.